Changes in nursing practice for patients undergoing high dose therapy with peripheral blood stem cell support.

被引：0
|
作者：
Brangan, E
Gupta, RK
机构：
[1] St Bartholomews Hosp, Dept Med Oncol, London, England
[2] St James Hosp, Dept Haematol, Dublin 8, Ireland
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
N920
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [21] An all oral antiemetic regimen for patients undergoing high-dose chemotherapy with peripheral blood stem cell transplant
    LA Frakes
    TL Brehm
    MP Kosty
    WE Miller
    RL McMillan
    J Mason
    BR Meisenberg
    Bone Marrow Transplantation, 1997, 20 : 473 - 478
  • [22] Phase I high dose 153samarium ethylenediaminetetramethylenephosphonate (153-Sm EDTMP) and melphalan therapy of multiple myeloma (MM) with peripheral blood stem cell (PBSC) support.
    Wiseman, GA
    Dispenzieri, A
    Anderson, PM
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 155P - 155P
  • [23] HIGH-DOSE THERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA
    KESSINGER, A
    ARMITAGE, JO
    SMITH, DM
    LANDMARK, JD
    BIERMAN, PJ
    WEISENBURGER, DD
    BLOOD, 1989, 74 (04) : 1260 - 1265
  • [24] Experience with liposomal amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation
    Kruger, WH
    Stockschlader, M
    Russmann, BC
    Hoffknecht, MM
    Sobottka, I
    Kroger, N
    Zander, AR
    BLOOD, 1995, 86 (10) : 3800 - 3800
  • [25] Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support
    Hensel, M
    Schneeweiss, A
    Sinn, HP
    Egerer, G
    Kornacker, M
    Solomayer, E
    Haas, R
    Bastert, G
    Ho, AD
    STEM CELLS, 2002, 20 (01) : 32 - 40
  • [26] Radiation therapy after high-dose chemotherapy with peripheral blood stem cell support for high-risk breast cancer
    Moreno, M
    Azinovic, I
    López-Picazo, JM
    Aramendía, JM
    Martínez-Monge, R
    Beltrán, C
    Aristu, JJ
    Rebollo, J
    Algarra, SM
    Fernández, O
    Brugarolas, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (04): : 347 - 353
  • [27] Sequential high-dose chemotherapy with peripheral blood stem cell (PBSC) support as adjuvant therapy for patients with high-risk breast cancer.
    Hohaus, S
    Wallwiener, D
    Schneeweiss, A
    Egerer, G
    Martin, S
    Abdallah, A
    Goldschmidt, H
    Fersis, N
    Bastert, G
    Haas, R
    BONE MARROW TRANSPLANTATION, 1998, 22 : S93 - S94
  • [28] Reduced dose of lenograstim is as efficacious as standard dose for peripheral blood stem cell mobilisation and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation
    Ozturk, M.
    Arpaci, F.
    Ataergin, S.
    Ozet, A.
    Cetin, T.
    Kuzhan, O.
    Ozturk, B.
    Komurcu, S.
    Kilic, S.
    Guler, T.
    Budakoglu, B.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S111 - S111
  • [29] Phase 2 trial of neumega(R) rhIL-11 in patients with breast cancer after high-dose chemotherapy with bone marrow and peripheral blood stem cell support.
    Hussein, A
    Fisher, D
    Vredenburgh, J
    Rubin, P
    Elkorky, M
    Peter, W
    Peret, N
    Dykstra, K
    Kaye, JA
    BLOOD, 1996, 88 (10) : 1189 - 1189
  • [30] High dose therapy with autologous peripheral blood stem cell (PBSC) support for Waldenstrom's Macroglobulinemia: A pilot study.
    Desikan, R
    Dhodapkar, M
    Siegel, D
    Fassas, A
    Singh, J
    Singhal, S
    Mehta, J
    Vesole, D
    Tricot, G
    Jagannath, S
    Kamble, R
    Anaissie, E
    Munshi, N
    Barlogie, B
    BLOOD, 1998, 92 (10) : 660A - 660A
12345